The ferguson operating anoscope for resection of T1 rectal cancer

Kristin C. Turza, Thomas Brien, Steven Porbunderwala, Christopher M. Bell, Shauna Lorenzo-Rivero, Richard A. Moore, Eric C. Nelson, John Stanley

Research output: Contribution to journalArticle

Abstract

The Ferguson Operating Anoscope (FOA) is a surgical instrument, which can facilitate transanal excision of appropriate rectal tumors within 15 cm of the anal verge. Previous work showed low recurrence (4.3%) for favorable T1 tumors (no lymphovascular invasion, well/moderate differentiation, negative margins). This follow-up study evaluates outcomes in rectal cancer excised with FOA at a tertiary care center. T1 rectal cancer patients were identified in a prospectively maintained database. Tumor pathology and patient characteristics were reviewed. Primary outcomes include tumor recurrence and patient and disease-free survival. Secondary outcomes are quality of excision (intact specimen). Twenty-eight patients had pathologic stage T1 rectal cancer (average 8-2.6 cm from the anal verge). Final path demonstrated 14 percent to be well differentiated, 82 percent moderately differentiated, and 93 percent without angiolymphatic invasion. All specimens removed were intact. One patient had a true local recurrence and underwent a salvage operation 24 months after her index operation. Patient survival was 96.4 percent (n 5 one death from primary lung cancer) at median follow-up 64 6 3-months.With appropriate tumor selection and quality of initial resection, FOA has demonstrated utility in achieving optimal oncologic resection of T1 rectal tumors.

Original languageEnglish (US)
Pages (from-to)1105-1108
Number of pages4
JournalAmerican Surgeon
Volume82
Issue number11
StatePublished - Nov 1 2016
Externally publishedYes

Fingerprint

Rectal Neoplasms
Recurrence
Neoplasms
Surgical Instruments
Tertiary Care Centers
Disease-Free Survival
Lung Neoplasms
Databases
Pathology
Survival

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Turza, K. C., Brien, T., Porbunderwala, S., Bell, C. M., Lorenzo-Rivero, S., Moore, R. A., ... Stanley, J. (2016). The ferguson operating anoscope for resection of T1 rectal cancer. American Surgeon, 82(11), 1105-1108.

The ferguson operating anoscope for resection of T1 rectal cancer. / Turza, Kristin C.; Brien, Thomas; Porbunderwala, Steven; Bell, Christopher M.; Lorenzo-Rivero, Shauna; Moore, Richard A.; Nelson, Eric C.; Stanley, John.

In: American Surgeon, Vol. 82, No. 11, 01.11.2016, p. 1105-1108.

Research output: Contribution to journalArticle

Turza, KC, Brien, T, Porbunderwala, S, Bell, CM, Lorenzo-Rivero, S, Moore, RA, Nelson, EC & Stanley, J 2016, 'The ferguson operating anoscope for resection of T1 rectal cancer', American Surgeon, vol. 82, no. 11, pp. 1105-1108.
Turza KC, Brien T, Porbunderwala S, Bell CM, Lorenzo-Rivero S, Moore RA et al. The ferguson operating anoscope for resection of T1 rectal cancer. American Surgeon. 2016 Nov 1;82(11):1105-1108.
Turza, Kristin C. ; Brien, Thomas ; Porbunderwala, Steven ; Bell, Christopher M. ; Lorenzo-Rivero, Shauna ; Moore, Richard A. ; Nelson, Eric C. ; Stanley, John. / The ferguson operating anoscope for resection of T1 rectal cancer. In: American Surgeon. 2016 ; Vol. 82, No. 11. pp. 1105-1108.
@article{4bd0927cf41e4619ac893e0dce59f51c,
title = "The ferguson operating anoscope for resection of T1 rectal cancer",
abstract = "The Ferguson Operating Anoscope (FOA) is a surgical instrument, which can facilitate transanal excision of appropriate rectal tumors within 15 cm of the anal verge. Previous work showed low recurrence (4.3{\%}) for favorable T1 tumors (no lymphovascular invasion, well/moderate differentiation, negative margins). This follow-up study evaluates outcomes in rectal cancer excised with FOA at a tertiary care center. T1 rectal cancer patients were identified in a prospectively maintained database. Tumor pathology and patient characteristics were reviewed. Primary outcomes include tumor recurrence and patient and disease-free survival. Secondary outcomes are quality of excision (intact specimen). Twenty-eight patients had pathologic stage T1 rectal cancer (average 8-2.6 cm from the anal verge). Final path demonstrated 14 percent to be well differentiated, 82 percent moderately differentiated, and 93 percent without angiolymphatic invasion. All specimens removed were intact. One patient had a true local recurrence and underwent a salvage operation 24 months after her index operation. Patient survival was 96.4 percent (n 5 one death from primary lung cancer) at median follow-up 64 6 3-months.With appropriate tumor selection and quality of initial resection, FOA has demonstrated utility in achieving optimal oncologic resection of T1 rectal tumors.",
author = "Turza, {Kristin C.} and Thomas Brien and Steven Porbunderwala and Bell, {Christopher M.} and Shauna Lorenzo-Rivero and Moore, {Richard A.} and Nelson, {Eric C.} and John Stanley",
year = "2016",
month = "11",
day = "1",
language = "English (US)",
volume = "82",
pages = "1105--1108",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "11",

}

TY - JOUR

T1 - The ferguson operating anoscope for resection of T1 rectal cancer

AU - Turza, Kristin C.

AU - Brien, Thomas

AU - Porbunderwala, Steven

AU - Bell, Christopher M.

AU - Lorenzo-Rivero, Shauna

AU - Moore, Richard A.

AU - Nelson, Eric C.

AU - Stanley, John

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The Ferguson Operating Anoscope (FOA) is a surgical instrument, which can facilitate transanal excision of appropriate rectal tumors within 15 cm of the anal verge. Previous work showed low recurrence (4.3%) for favorable T1 tumors (no lymphovascular invasion, well/moderate differentiation, negative margins). This follow-up study evaluates outcomes in rectal cancer excised with FOA at a tertiary care center. T1 rectal cancer patients were identified in a prospectively maintained database. Tumor pathology and patient characteristics were reviewed. Primary outcomes include tumor recurrence and patient and disease-free survival. Secondary outcomes are quality of excision (intact specimen). Twenty-eight patients had pathologic stage T1 rectal cancer (average 8-2.6 cm from the anal verge). Final path demonstrated 14 percent to be well differentiated, 82 percent moderately differentiated, and 93 percent without angiolymphatic invasion. All specimens removed were intact. One patient had a true local recurrence and underwent a salvage operation 24 months after her index operation. Patient survival was 96.4 percent (n 5 one death from primary lung cancer) at median follow-up 64 6 3-months.With appropriate tumor selection and quality of initial resection, FOA has demonstrated utility in achieving optimal oncologic resection of T1 rectal tumors.

AB - The Ferguson Operating Anoscope (FOA) is a surgical instrument, which can facilitate transanal excision of appropriate rectal tumors within 15 cm of the anal verge. Previous work showed low recurrence (4.3%) for favorable T1 tumors (no lymphovascular invasion, well/moderate differentiation, negative margins). This follow-up study evaluates outcomes in rectal cancer excised with FOA at a tertiary care center. T1 rectal cancer patients were identified in a prospectively maintained database. Tumor pathology and patient characteristics were reviewed. Primary outcomes include tumor recurrence and patient and disease-free survival. Secondary outcomes are quality of excision (intact specimen). Twenty-eight patients had pathologic stage T1 rectal cancer (average 8-2.6 cm from the anal verge). Final path demonstrated 14 percent to be well differentiated, 82 percent moderately differentiated, and 93 percent without angiolymphatic invasion. All specimens removed were intact. One patient had a true local recurrence and underwent a salvage operation 24 months after her index operation. Patient survival was 96.4 percent (n 5 one death from primary lung cancer) at median follow-up 64 6 3-months.With appropriate tumor selection and quality of initial resection, FOA has demonstrated utility in achieving optimal oncologic resection of T1 rectal tumors.

UR - http://www.scopus.com/inward/record.url?scp=85015603096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015603096&partnerID=8YFLogxK

M3 - Article

VL - 82

SP - 1105

EP - 1108

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 11

ER -